Chinese Medical Association Publishing House (CMAPH)

The Chinese Medical Association Publishing House (CMAPH) is the leading and largest medical journal publisher in China. As the publishing arm of the Chinese Medical Association (CMA), it manages a prestigious cluster of over 190 medical journals, including the foundational 'Chinese Medical Journal' (est. 1887) and the 'National Medical Journal of China'. The company serves as a critical bridge between the Chinese medical community and global healthcare research, providing a primary platform for clinical trials, expert consensuses, and clinical practice guidelines. While not a drug developer, CMAPH is an essential stakeholder in the pharmaceutical industry, as its journals publish the pivotal data and regulatory-standard guidelines that dictate therapeutic adoption in China. Recently, the organization has pivoted toward digital health and knowledge services, launching specialized platforms for clinical case databases and intensifying its focus on the 'China Scientific Journal Excellence Action Plan' to elevate Chinese medical research to international standards.